María J. Vicent

Best Publications

• Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.

  Francesca Greco;María J. Vicent

  724
  Citations

• Polymer conjugates: nanosized medicines for treating cancer

  María J. Vicent;Ruth Duncan

  599
  Citations

• Polymer therapeutics-prospects for 21st century: the end of the beginning.

  Ruth Duncan;María J. Vicent

  486
  Citations

• Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

  Matthias Barz;Robert Luxenhofer;Rudolf Zentel;María J. Vicent

  461
  Citations

• Current hurdles to the translation of nanomedicines from bench to the clinic

  Snežana Đorđević;María Medel Gonzalez;Inmaculada Conejos-Sánchez;Barbara Carreira

  428
  Citations

• Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities

  Ruth Duncan;María J. Vicent

  284
  Citations

• Polymer therapeutics designed for a combination therapy of hormone-dependent cancer.

  María J. Vicent;Francesca Greco;Robert I. Nicholson;Alison Paul

  258
  Citations

• Polymer therapeutics: clinical applications and challenges for development.

  María J. Vicent;Helmut Ringsdorf;Ruth Duncan

  228
  Citations

• Polymer--drug conjugates as nano-sized medicines.

  Fabiana Canal;Joaquin Sanchis;María Jesús Vicent

  184
  Citations

• Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel

  Anat Eldar-Boock;Keren Miller;Joaquin Sanchis;Ruth Lupu

  146
  Citations

• A controlled and versatile NCA polymerization method for the synthesis of polypeptides

  Inmaculada Conejos-Sánchez;Aroa Duro-Castano;Alexander Birke;Matthias Barz

  135
  Citations

• How Important is the Inert Matrix of Supported Enantiomeric Catalysts? Reversal of Topicity with Two Polystyrene Backbones We would like to warmly thank Prof. J. M. J. Fréchet and Dr. F. Svec for technical advice. Financial support for this work was provided by the Spanish C.I.C.Y.T. (Project MAT96-1053) and Fundació Caixa Castelló-Bancaixa (P1B97-10).

  B Altava;MI Burguete;JM Fraile;JI García

  127
  Citations

• The past, present, and future of breast cancer models for nanomedicine development.

  Paz Boix-Montesinos;Paula M. Soriano-Teruel;Ana Armiñán;Mar Orzáez

  123
  Citations

• How Important is the Inert Matrix of Supported Enantiomeric Catalysts? Reversal of Topicity with Two Polystyrene Backbones

  Belén Altava;M. Isabel Burguete;José M. Fraile;José I. García

  121
  Citations

• Peptide-Based Polymer Therapeutics

  Aroa Duro-Castano;Inmaculada Conejos-Sánchez;María J. Vicent

  121
  Citations

• Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer–Dox–AGM in breast cancer cells

  F. Greco;M. J. Vicent;S. Gee;Arwyn Tomos Jones

  114
  Citations

• Smart branched polymer drug conjugates as nano-sized drug delivery systems

  A. Duro-Castano;J. Movellan;M. J. Vicent

  105
  Citations

• Polymer–drug conjugates for novel molecular targets

  Joaquin Sanchis;Fabiana Canal;Rut Lucas;María J Vicent

  105
  Citations

• Polymer conjugates as therapeutics: future trends, challenges and opportunities

  María J Vicent;Lucile Dieudonné;Rodrigo J Carbajo;Antonio Pineda-Lucena

  103
  Citations

• Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.

  Fabiana Canal;María J. Vicent;Gianfranco Pasut;Oddone Schiavon

  100
  Citations